INS and type 1 diabetes mellitus: The phenomenon is particularly evident in overweight and obese T1D individuals in whom adjuvant non‐insulin treatment may be essential to ameliorate insulin sensitivity, attenuate glycemic excursions, improve overall glucose control, reduce insulin requirement, lessen food and carbohydrate intake, and consequently induce weight loss or avoid weight gain [84].